TGTX
TG Therapeutics Inc
NASDAQ: TGTX · HEALTHCARE · BIOTECHNOLOGY
$33.58
-2.89% today
Updated 2026-04-29
Market cap
$5.36B
P/E ratio
12.12
P/S ratio
8.70x
EPS (TTM)
$2.77
Dividend yield
—
52W range
$25 – $46
Volume
2.0M
TG Therapeutics Inc (TGTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
72.60%
Operating margin
26.20%
ROE
102.80%
ROA
9.39%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-9.70M | — | — | — |
| 2007 | — | $-12.03M | — | — | — |
| 2008 | — | $-4.27M | — | — | — |
| 2009 | — | $-2.79M | — | — | — |
| 2010 | — | $623645.00 | — | — | — |
| 2011 | $0.00 | $-853074.00 | — | — | — |
| 2012 | $19048.00 | $-18.07M | 100.00% | -141,196.45% | -94,879.88% |
| 2013 | $152381.00 | $-20.48M | 100.00% | -15,071.43% | -13,438.82% |
| 2014 | $152381.00 | $-55.78M | 100.00% | -36,566.96% | -36,606.45% |
| 2015 | $152381.00 | $-62.95M | 100.00% | -41,461.87% | -41,310.04% |
| 2016 | $152381.00 | $-78.25M | 100.00% | -51,823.47% | -51,353.45% |
| 2017 | $152381.00 | $-118.48M | 100.00% | -77,904.56% | -77,749.86% |
| 2018 | $152000.00 | $-173.48M | 42.11% | -114,736.84% | -114,132.89% |
| 2019 | $152000.00 | $-172.87M | 100.00% | -111,220.39% | -113,730.92% |
| 2020 | $152000.00 | $-279.38M | 100.00% | -179,996.05% | -183,803.29% |
| 2021 | $6.69M | $-348.10M | 88.19% | -5,154.28% | -5,204.08% |
| 2022 | $2.79M | $-223.81M | 90.48% | -7,838.99% | -8,036.34% |
| 2023 | $233.66M | $12.67M | 93.95% | 8.83% | 5.42% |
| 2024 | $329.00M | $23.38M | 88.30% | 12.74% | 7.11% |
| 2025 | $616.29M | $447.18M | 83.62% | 20.01% | 72.56% |